Raising awareness and generating change for the 300 million people worldwide living with a rare disease, their families and carers.*
This year, Rare Diseases Day (RDD) falls on the rarest day of all in 2024 – 29 February! The event, held annually, aims to raise awareness of rare diseases and their impact on those living with them, their families, and caregivers.
At Janssen, we are committed to this goal, and are working to drive change for the 300 million people worldwide (and approximately 30 million in Europe) who are living with one of the 6,000-plus rare diseases. Our participation in awareness events, such as RDD, is an integral part of this.
We make strides by focused research and development programs to ultimately bring new, groundbreaking medicines to those affected by rare diseases. With our expertise in therapeutic areas like Pulmonary Hypertension, Retina, Immunology, Oncology and Neuroscience, we leverage scientific and operational knowledge to make a difference. Collaborating globally with partners and utilizing innovative tools, we are invested in improving health outcomes for individuals impacted by rare diseases.
At Janssen, we understand the importance of time for those affected by rare diseases. Patients shouldn't have to wait endlessly for diagnosis and treatment. That's why we focus on areas where we have the potential to make a substantial impact, including rare diseases. We tirelessly advance the science and chase breakthroughs in conditions like pulmonary arterial hypertension (PAH), AL amyloidosis, myasthenia gravis, rare inherited retinal diseases, rare maternal-fetal diseases, and rare blood disorders and cancers.
Our work at Janssen is fueled by the vision of a future where disease is a thing of the past. We are dedicated to finding lasting solutions and never cease in our pursuit.
See examples of how we’re raising awareness for people living with rare disease.